HILLARY MORRIS: Open Payments
NPI 1790971356 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 71 payments from 20 companies in 2025. Trend: 2023 $1,464 · 2024 $1,788 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $185 |
| PFIZER INC. | 10 | $180 |
| GlaxoSmithKline, LLC. | 11 | $160 |
| Lilly USA, LLC | 6 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $121 |
| Amgen Inc. | 3 | $57 |
| Corcept Therapeutics | 3 | $56 |
| Exact Sciences Corporation | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, JARDIANCE, Wegovy, AIRSUPRA, ZEPBOUND, Ozempic, Korlym.
Industry payments across FL — which companies pay providers there.
